| Treatment of Fabry’s disease with the pharmacologic chaperone migalastat DP Germain, DA Hughes, K Nicholls, DG Bichet, R Giugliani, WR Wilcox, ... New england journal of medicine 375 (6), 545-555, 2016 | 587 | 2016 |
| Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology C Feliciani, P Joly, MF Jonkman, G Zambruno, D Zillikens, D Ioannides, ... British journal of dermatology 172 (4), 867-877, 2015 | 344 | 2015 |
| Pemphigus. S2 Guideline for diagnosis and treatment–guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV) M Hertl, H Jedlickova, S Karpati, B Marinovic, S Uzun, S Yayli, D Mimouni, ... Journal of the European Academy of Dermatology and Venereology 29 (3), 405-414, 2015 | 344 | 2015 |
| Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data A Mehta, M Beck, P Elliott, R Giugliani, A Linhart, G Sunder-Plassmann, ... The Lancet 374 (9706), 1986-1996, 2009 | 335 | 2009 |
| Diagnosis and management of pemphigus: Recommendations of an international panel of experts DF Murrell, S Peña, P Joly, B Marinovic, T Hashimoto, LA Diaz, AA Sinha, ... Journal of the American Academy of Dermatology 82 (3), 575-585. e1, 2020 | 322 | 2020 |
| Fabry disease: a review of current management strategies A Mehta, M Beck, F Eyskens, C Feliciani, I Kantola, U Ramaswami, ... QJM: An International Journal of Medicine 103 (9), 641-659, 2010 | 280 | 2010 |
| Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV) P Joly, B Horvath, Α Patsatsi, S Uzun, R Bech, S Beissert, R Bergman, ... Journal of the European Academy of Dermatology and Venereology 34 (9), 1900-1913, 2020 | 242 | 2020 |
| In vitro and in vivo expression of interleukin-1α and tumor necrosis factor-α mRNA in pemphigus vulgaris: interleukin-1α and tumor necrosis factor-α are involved in acantholysis C Feliciani, P Toto, SM Pour, G Coscione, P Amerio, P Amerio, G Shivji, ... Journal of Investigative Dermatology 114 (1), 71-77, 2000 | 202 | 2000 |
| Enhanced epidermal Langerhans cell migration in IL-10 knockout mice B Wang, L Zhuang, H Fujisawa, GA Shinder, C Feliciani, GM Shivji, ... The Journal of Immunology 162 (1), 277-283, 1999 | 184 | 1999 |
| Keratinocytes and cytokine/growth factors C Feliciani, AK Gupta, DN Saucier Critical Reviews in Oral Biology & Medicine 7 (4), 300-318, 1996 | 174 | 1996 |
| Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines M Reale, C Iarlori, F Gambi, C Feliciani, A Salone, L Toma, G DeLuca, ... Journal of neuroimmunology 148 (1-2), 162-171, 2004 | 151 | 2004 |
| Monocyte chemotactic protein-1 provokes mast cell aggregation and [3H] 5HT release. P Conti, W Boucher, R Letourneau, C Feliciani, M Reale, RC Barbacane, ... Immunology 86 (3), 434, 1995 | 140 | 1995 |
| Peripheral chemokine receptors, their ligands, cytokines and Alzheimer's disease M Reale, C Iarlori, C Feliciani, D Gambi Journal of Alzheimer's Disease 14 (2), 147-159, 2008 | 132 | 2008 |
| Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications P Amerio, A Frezzolini, C Feliciani, R Verdolini, P Teofoli, O Pit, P Puddu Current Drug Targets-Inflammation & Allergy 2 (1), 81-94, 2003 | 130 | 2003 |
| The role of interleukin 10 in the pathogenesis and potential treatment of skin diseases E Weiss, AJ Mamelak, S La Morgia, B Wang, C Feliciani, A Tulli, ... Journal of the American Academy of Dermatology 50 (5), 657-675, 2004 | 127 | 2004 |
| Vitiligo associated with other autoimmune diseases: polyglandular autoimmune syndrome types 3B+ C and 4 P Amerio, M Tracanna, P De Remigis, C Betterle, L Vianale, ME Marra, ... Clinical and experimental dermatology 31 (5), 746-749, 2006 | 115 | 2006 |
| European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology–Part II E Schmidt, H Rashid, AV Marzano, A Lamberts, G Di Zenzo, GFH Diercks, ... Journal of the European Academy of Dermatology and Venereology 35 (10), 1926 …, 2021 | 101 | 2021 |
| Nail psoriasis: combined therapy with systemic cyclosporin and topical calcipotriol C Feliciani, A Zampetti, P Forleo, L Cerritelli, P Amerio, G Proietto, A Tulli, ... Journal of cutaneous medicine and surgery 8 (2), 122-125, 2004 | 93 | 2004 |
| European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology–Part I H Rashid, A Lamberts, L Borradori, S Alberti‐Violetti, RJ Barry, M Caproni, ... Journal of the European Academy of Dermatology and Venereology 35 (9), 1750-1764, 2021 | 84 | 2021 |
| Angiokeratoma: decision‐making aid for the diagnosis of Fabry disease A Zampetti, CH Orteu, D Antuzzi, MR Bongiorno, S Manco, M Gnarra, ... British Journal of Dermatology 166 (4), 712-720, 2012 | 82 | 2012 |
paolo amerioClinica Dermatologica Università Chieti-PescaraVerified email at unich.it
